Oracle Acquires Phase Forward

Apr 22, 2010


      Bookmark and Share

Oracle announced that it has agreed to acquire Phase Forward, a provider of clinical and drug safety solutions. Oracle hopes to use the acquisition to bolster its Health Sciences Suite with tools that will enable researchers and others to more effectively and securely capture and share data.

Phase Forward's Integrated Clinical Research Suite allows life sciences companies to automate and integrate the management of their clinical development process from Phase I trials through regulatory submission, Phase IV trials, and pharmaco-vigilance.

(www.oracle.com)